On the other hand, mTOR inhibitors are reported to exert promising effects by restricting cancer by their kinase activity targeting the downstream mTOR kinase molecules of PTEN in KSHV-infected cells (Mohanty et al., 2017). Here, PTEN is linked to cancer.